What Is Celldex Therapeutics, Inc. (CLDX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Celldex Therapeutics, Inc.'s intrinsic value is estimated at $9.13, suggesting the stock is overvalued at its current price of $38.53. With 11 out of 12 models flagging downside (-76.3% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $38.10 (-1.1%), versus Sentiment SOTP at $0.58 (-98.5%). This +97.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About CLDX?
12 of 13 models are currently active for CLDX. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates CLDX's intrinsic value at $11.87, implying -69.2% downside from the current price. See which stocks rank higher →
How Does CLDX Rank in In Vitro & In Vivo Diagnostic Substances?
Among 17 In Vitro & In Vivo Diagnostic Substances stocks, CLDX ranks #7 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.
Celldex Therapeutics, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is CLDX a Value Trap?
CirclFi's Value Trap algorithm assigns CLDX a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Celldex Therapeutics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Celldex Therapeutics, Inc. is rated at 6.1/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.
The gap between the most bullish and bearish model spans +97.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CLDX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CLDX's 12 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad